- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Abbott launches Amplatzer Talisman PFO Occlusion System in Europe to close hole in heart for people at risk of recurrent stroke
Abbott Park, Ill.: Abbott has announced the European launch of its Amplatzer Talisman PFO Occlusion System to treat people with a patent foramen ovale (PFO) – a hole in the heart that doesn't close following birth – who have experienced a stroke and are at risk of having another. The new Talisman PFO occluders come pre-attached to the delivery cable, designed to reduce preparation time for doctors and making the system easier to use.
Nearly one in four people have a PFO, which may allow blood clots to pass from the right side of the heart to the left, from where they can eventually travel to the brain. For patients who have suffered a stroke, physicians may opt for occlusion (or closure) of the PFO through a minimally invasive, catheter-based procedure using a device like the Talisman system to seal off the opening to reduce the risk of another stroke.
"Guidelines from industry organizations and clinical trial data continue to reinforce the benefits of PFO closure for people who have had a PFO-associated stroke," said Matthew Daniels, BSc, MA, MB BChir, MRCP, FSCAI, honorary consultant cardiologist in Manchester, England, who completed the first European procedure with the Talisman system. "We're excited that physicians around Europe now have access to the Talisman device to help reduce patients' risk and worry of experiencing another stroke."
The Amplatzer Talisman system builds off the company's industry-leading Amplatzer PFO Occluder. While physicians had to attach the Amplatzer PFO Occluder to the delivery cable before performing the implant procedure, the Talisman occluder now comes pre-assembled to the Amplatzer Trevisio delivery cable, reducing prep time ahead of the procedure and making it easier to use. The Talisman system accommodates a wide range of patient anatomies and an updated 30mm occluder size optimizes how it fits in the heart. The Talisman device is fully recapturable and repositionable so doctors can easily make adjustments for accurate placement.
"Our trusted PFO closure technology has been used to treat more than 180,000 people worldwide and we haven't let up on continuing to innovate to best serve physicians and patients," said Michael Dale, senior vice president of Abbott's structural heart business. "The Talisman system simplifies the procedure for doctors and helps patients quickly get back to living fuller, healthier lives."
Read also: Abbott gets USFDA nod for new Proclaim Plus spinal cord stimulation device
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751